MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 912938 Boston, MA

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$27,583,169

+$6,493,374 QoQ

Shares Held

431,324

-1.5% QoQ

Ownership

0.276%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#28

of 264 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 99% Shared 1% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $152,241,305 across 13 Drug Manufacturers - Specialty & Generic names. KNSA ranks #3 (18.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COLL	Collegium Pharmaceutical, Inc	1,405,567	$50,881,525
2	PBH	Prestige Consumer Healthcare Inc.	629,836	$29,772,346
3	KNSA	Kiniksa Pharmaceuticals International, plc This page	431,324	$27,583,169
4	NBIX	Neurocrine Biosciences Inc	102,414	$17,260,854
5	HLN	Haleon plc	957,121	$8,929,938
6	RDY	Dr Reddys Laboratories Ltd	475,589	$6,891,283
7	INDV	Indivior Pharmaceuticals, Inc.	144,366	$5,923,336
8	ZTS	Zoetis Inc.	18,655	$1,340,547

All Filings in KNSA

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,583,169	431,324	-1.5%	Shares	Sole	2026-08-03
2026-03-31	$21,089,795	438,002	+3.0%	Shares	Sole	2026-05-14
2025-12-31	$17,540,819	425,232	-7.2%	Shares	Sole	2026-01-22
2025-09-30	$17,795,944	458,304	+613.5%	Shares	Sole	2025-10-29
2025-06-30	$1,777,299	64,232	+1.3%	Shares	Sole	2025-08-08
2025-03-31	$1,408,980	63,439	-2.2%	Shares	Sole	2025-05-02
2024-12-31	$1,283,346	64,881	-2.9%	Shares	Sole	2025-02-12
2024-09-30	$1,669,731	66,816	-2.4%	Shares	Sole	2024-11-12
2024-06-30	$1,277,662	68,434	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.